Trial targeting tumours
A new device that targets hard-to-kill tumours is the focus of a research trial led by The Alfred's interventional radiology team.
COVID-19: Find out about our screening clinic - and note our current visitor restrictions
In 2019, the Federal Government awarded Alfred Health $24.6M to oversee, and lead, a new initiative to improve the access of cancer clinical trials in regional and remote parts of Victoria.
In collaboration with Monash University, TrialHub’s initial focus is on melanoma, prostate and rare cancer and rare disease trials but is expected to expand into other clinical trial areas over the next few years.
Alfred Cancer Trials (ACT) has extensive expertise in conducting sponsored, collaborative and investigator-led Phase I, II, III and IV clinical trials.
Patients with poor access to clinical trial programs don’t always gain early access to breakthroughs in medical treatment.
We have been established to coordinate and support the equitable access of high-quality, and safe, clinical trials for Victorians, no matter where they live.
Over the next five years, TrialHub, which is based within Alfred Health, will partner with hospitals to boost the number of available clinical trials by facilitating long-term, sustainable clinical trial units across outer metro, regional and rural Victoria.
Leveraging existing clinical trial excellence, TrialHub will achieve this by undertaking a number of flagship projects.
These projects include:
TrialHub has already partnered with Latrobe Regional Hospital, Bendigo Health and Peninsula Health (Rosebud Hospital), with further regional hospitals expected to join later in the year.
TrialHub is being monitored at a national level as it’s expected to be replicated and expanded across Australia within the next three to five years.
This investment is through the Federal Government’s Community Health and Hospitals Program.
A new device that targets hard-to-kill tumours is the focus of a research trial led by The Alfred's interventional radiology team.